← Leaderboards
Min Yu
University Of Southern California
$5,786,686
Attributed
$6,430,289
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,430,289 · 5
By mechanism
R01$3,093,090 · 2
DP2$2,616,176 · 1
K22$592,272 · 1
P30$128,751 · 1
Top collaborators
- Jennifer Richer-Mouchantat2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Lon S Schneider$40,841,066
- Timothy J. Triche$21,258,785
- Arthur W Toga$135,966,223
- Daniel O Stram$3,536,343
- Bhavna Shamasunder$1,509,328
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmNeoplasm Circulating CellsCellsSignal TransductionNeoplastic CellMalignant NeoplasmsMediatingTumorTargeted TreatmentPreventMolecularBreast Cancer CellComplexIn VivoPathway InteractionsBreast Cancer PatientMortalityIn VitroMouse ModelBloodLinkOverexpressionCancer TypeBlood Circulation
Grant awards (13)
The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer$630,810
R01 · FY2025 · CA · contact PI
Hormone Related Cancers Program$128,751
P30 · FY2025 · CA · contact PI
The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer$656,397
R01 · FY2024 · CA · contact PI
Mechanisms of SEMA4D mediated breast cancer to brain metastasis$336,254
R01 · FY2024 · CA · contact PI
Mechanisms of SEMA4D mediated breast cancer to brain metastasis$344,864
R01 · FY2023 · CA · contact PI
Mechanisms of SEMA4D mediated breast cancer to brain metastasis$369,889
R01 · FY2022 · CA · contact PI
Mechanisms of SEMA4D mediated breast cancer to brain metastasis$377,438
R01 · FY2021 · CA · contact PI
Mechanisms of SEMA4D mediated breast cancer to brain metastasis$377,438
R01 · FY2020 · CA · contact PI
Developing Individualized Medicine Targeting Metastatic Breast Cancer Stem Cells$141,176
DP2 · FY2019 · CA · contact PI
Characterizing the role of TAK1 in breast cancer metastasis$197,424
K22 · FY2016 · CA · contact PI
Developing Individualized Medicine Targeting Metastatic Breast Cancer Stem Cells$2,475,000
DP2 · FY2015 · CA · contact PI
Characterizing the role of TAK1 in breast cancer metastasis$197,424
K22 · FY2015 · CA · contact PI
Characterizing the role of TAK1 in breast cancer metastasis$197,424
K22 · FY2014 · CA · contact PI